Cerus reported $-6073000 in EBITDA for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebitda Change
Atrion ATRI:US USD 14.48M 3.28M
Cytori Therapeutics CYTX:US USD -4936000 29K
Meridian Bioscience VIVO:US USD 13.03M 435K
Neogen NEOG:US USD 44.48M 18.99M
Nuvasive NUVA:US USD 61.5M 436K
Orasure Technologies OSUR:US USD 11.36M 18.33M
Rockwell Medical RMTI:US USD -3467000 774K